CytoAurora Wins Scale-up Award in South Korea, Showcasing a Double Win on the Global Stage

Under the leadership of Dr. Kich Aungvitulsatit, Executive of CytoAurora Biotechnology (Thailand) Co., Ltd., the company has announced a historic achievement on the global stage by winning the “Scale-up Award” at the Global Innovation Forum (GIF), organized by the Government of South Korea in Las Vegas, USA, following CES 2026.

This milestone reinforces CytoAurora’s position as a leading Thai–Taiwanese Deep Tech innovator, poised to transform cancer screening on a global scale.

The award-winning innovation is a high-precision liquid biopsy system for detecting and screening cancer cells from blood samples. This technology was developed in collaboration with CytoAurora’s parent company, located in Hsinchu Science Park, Taiwan, a global hub for innovation.

The system enables rapid and highly accurate cancer detection using only a blood test, significantly improving treatment opportunities while greatly reducing the burden on patients.

The Scale-up Award by the Government of South Korea focuses on identifying businesses with cutting-edge innovations and clear plans for entering international markets. CytoAurora Biotechnology plans to leverage the collaborations and investor networks gained from this platform to expand its service and research presence to leading medical markets across Asia and the West.